Adult human mesenchymal stromal cells and the treatment of graft versus host disease
Richard P Herrmann, Marian J Sturm Cell and Tissue Therapies, Western Australia, Royal Perth Hospital, Wellington Street, Perth, WA, Australia Abstract: Graft versus host disease is a difficult and potentially lethal complication of hematopoietic stem cell transplantation. It occurs with minor hum...
Main Authors: | Herrmann RP, Sturm MJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-02-01
|
Series: | Stem Cells and Cloning : Advances and Applications |
Online Access: | http://www.dovepress.com/adult-human-mesenchymal-stromal-cells-and-the-treatment-of-graft-versu-a15988 |
Similar Items
-
Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment
by: L. A. Kuzmina, et al.
Published: (2020-09-01) -
Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
by: Cynthia Morata-Tarifa, et al.
Published: (2020-02-01) -
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
by: Tik Shing Cheung, et al.
Published: (2020-06-01) -
Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
by: Juliana A. P. Godoy, et al.
Published: (2019-11-01) -
Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
by: Neil Dunavin, et al.
Published: (2017-07-01)